Quant Imaging Med Surg. 2014 Jun;4(3):173-80. doi: 10.3978/j.issn.2223-4292.2014.05.01.
Chemical shift imaging: preliminary experience as an alternative sequence for defining the extent of a bone tumor.
Quantitative imaging in medicine and surgery
Filippo Del Grande, Ney Tatizawa-Shiga, Sahar Jalali Farahani, Majid Chalian, Laura Marie Fayad
Affiliations
Affiliations
- 1 The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins Medical Institutions, 601 North Wolfe Street, Baltimore, MD 21287, USA ; 2 Ospedale Regionale di Lugano, Via Tesserete, 6900 Lugano, Ti Switzerland.
PMID: 24914418
PMCID: PMC4032920 DOI: 10.3978/j.issn.2223-4292.2014.05.01
Abstract
OBJECTIVE: To investigate chemical shift imaging (CSI) with in-phase and opposed-phase (OP) gradient-echo sequences as an alternative sequence to spin-echo T1 imaging for defining intra-medullary skeletal tumor extent.
METHODS AND MATERIALS: This retrospective HIPAA-compliant study was approved by our institutional institutional review board (IRB). Twenty-three subjects with histologically-proven tumors (17 appendicular, 6 axial) underwent magnetic resonance imaging (MRI) with T1-weighted spin echo (T1SE), fluid-sensitive, CSI, and contrast-enhanced T1 sequences. One observer recorded intra-medullary tumor extent (millimeters), with 153 total measurements on each sequence. Red marrow grade [0 (none), 1 (<50%), 2 (50-75%) and 3 (>75%)] in each bone was recorded. Tumor extent on different sequences was compared (Student's t-test); the impact of red marrow grade on measurements was assessed (Spearman's correlation coefficient).
RESULTS: There was good agreement between measurements of tumor extent on T1SE and CSI sequences in all cases (T1SE-CSI measurement difference range 0-13.2 mm, P>0.05). Measurements from other sequences were significantly different from those of T1SE (P<0.05). As red marrow grade in the bone increased, a significant increase in measurement difference obtained on T1SE and CSI sequences was observed (P<0.001).
CONCLUSIONS: CSI is a potential alternative technique to T1SE imaging for defining the intra-medullary extent of a bone tumor, possibly especially useful in regions with abundant red marrow.
ADVANCE IN KNOWLEDGE: CSI could be an alternative technique to T1SE imaging for defining the intra-medullary extent of bone tumor by abundant red marrow in the surrounding bone.
Keywords: Bone marrow lesion; chemical shift imaging (CSI); magnetic resonance imaging (MRI); red bone marrow
References
- Eur Radiol. 1998;8(8):1327-34 - PubMed
- AJR Am J Roentgenol. 2009 Sep;193(3 Suppl):S1-4, Quiz S5-9 - PubMed
- AJNR Am J Neuroradiol. 2006 Jun-Jul;27(6):1183-8 - PubMed
- Radiology. 1989 Jun;171(3):767-73 - PubMed
- AJR Am J Roentgenol. 1993 Dec;161(6):1217-21 - PubMed
- AJR Am J Roentgenol. 1991 Aug;157(2):347-51 - PubMed
- AJR Am J Roentgenol. 1997 Nov;169(5):1439-47 - PubMed
- Eur J Radiol. 2000 Jun;34(3):229-46 - PubMed
- AJR Am J Roentgenol. 1997 Jul;169(1):191-6 - PubMed
- AJR Am J Roentgenol. 1992 Feb;158(2):335-8 - PubMed
- Radiology. 2005 Nov;237(2):590-6 - PubMed
- AJR Am J Roentgenol. 1996 Nov;167(5):1211-5 - PubMed
- J Magn Reson Imaging. 2004 Dec;20(6):1020-4 - PubMed
- Radiology. 1988 Jun;167(3):765-7 - PubMed
- Eur Radiol. 2002 Jul;12(7):1811-8 - PubMed
Publication Types